Date: Tuesday 26 Apr 2011
Shareholders in allergy vaccine developer Allergy Therapeutics were making hay Tuesday after the US Food and Drug Administration (FDA) signalled the imminent lifting of the clinical hold on three of the company's products.
| London close: Flat day for FTSE 100 | 28-Mar-2011 | ShareCast |
| London afternoon: Shares mark time | 28-Mar-2011 | ShareCast |
| Weak German market hits sales at Allergy Therape... | 28-Mar-2011 | ShareCast |
| Small caps: Allergy Therapeutics, Goldplat, Avacta | 20-Sep-2010 | ShareCast |
| Cairn boss raises nearly £3m | 24-Mar-2010 | ShareCast |
| Voluntary recall of Anapen by Lincoln Medical | 23-May-2012 | 11:23 | RNS |
| Holding(s) in Company | 17-May-2012 | 16:51 | RNS |
| Holding(s) in Company | 17-May-2012 | 16:51 | RNS |
| Total Voting Rights | 16-May-2012 | 11:11 | RNS |
| Board Appointment | 02-May-2012 | 15:33 | RNS |
| Allergy drug firm hit by trials setback | 12-Jul-2007 | The Independent |
| Need to Know: Global Business Briefing | 25-Mar-2006 | Times |
| FTSE Close: BP and Lloyds lead rally | 21-Sep-2010 | Daily Mail |
| Tempus:Allergy Therapeutics | 22-Sep-2009 | Times |
| Investment Column:Allergy Therapeutics | 22-Sep-2009 | The Independent |
| Market report: Wednesday lastest | 14-May-2008 | Daily Mail |
| Market Report: Prudential gains after bid specul... | 13-Mar-2008 | The Independent |
No recent information was found.
| FTSE in-depth: Even Primark feels the pinch | 27-Apr-2011 | This Is Money |
| FTSE preview: Shares up as banks bounce | 18-Nov-2010 | This Is Money |
| FTSE Close: BP and Lloyds lead rally | 20-Sep-2010 | This Is Money |
| FTSE 100 preview: Shares up; Fed wait | 20-Sep-2010 | This Is Money |
| Newspaper and magazine share tips | 22-Sep-2009 | This Is Money |
| Currency | UK Pounds |
| Share Price | 7.88p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 15.63 |
| 52 Week Low | 7.74 |
| Volume | 50,221,642 |
| Shares Issued | 406.91m |
| Market Cap | £32.04m |
| Beta | 0.27 |
| RiskGrade | 148 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 16:39 | 10,000 @ 8.00p |
| 16:30 | 16,732,764 @ 7.74p |
| 16:28 | 10,000 @ 8.00p |
| 16:19 | 16,732,764 @ 7.75p |
| 16:19 | 16,732,764 @ 7.75p |
| Finance Director | Ian D Postlewaite |
| CEO | Manuel Llobet |
You are here: research